| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/16/2006 | CA2575039A1 Novel cyclic amino benzoic acid derivative |
| 02/16/2006 | CA2571143A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 02/16/2006 | CA2570324A1 Rage fusion proteins and methods of use |
| 02/15/2006 | EP1625870A2 Needle for intradermal delivery of substances having penetration limiting means |
| 02/15/2006 | EP1625847A1 Pharmaceutical composition comprising a tetrahydrotriazolo[4,3-a]pyrazine |
| 02/15/2006 | EP1625207A2 Compounds for treatment of inflammation, diabetes and related disorders |
| 02/15/2006 | EP1625112A1 Novel compounds for treatment of obesity |
| 02/15/2006 | EP1624874A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/15/2006 | EP1624871A1 Method of treating atherosclerosis, dyslipidemias and related conditions and pharmaceutical compositions |
| 02/15/2006 | EP1624856A2 Method of preparing a formulation containing a microdosed active principle |
| 02/15/2006 | EP1482787A4 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 02/15/2006 | EP1341533B1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 02/15/2006 | EP1224207B1 5-hydroxysapogenin derivatives with anti-dementia activity |
| 02/15/2006 | CN1735613A 稠合杂环化合物 Fused heterocyclic compounds |
| 02/15/2006 | CN1735611A CB 1 receptor inverse agonists |
| 02/15/2006 | CN1735595A Substituted alkyl amido piperidines |
| 02/15/2006 | CN1735593A Novel CB1 receptour inverse agonists |
| 02/15/2006 | CN1735423A Treatment of gastroparesis |
| 02/15/2006 | CN1735416A Therapeutic combination |
| 02/15/2006 | CN1735415A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/15/2006 | CN1735411A Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes by increasing the number of islets of langerhans cells |
| 02/15/2006 | CN1735410A Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes by increasing the number of islets of langerhans cells |
| 02/15/2006 | CN1735409A Imidazol derivatives having affinity for alpha 2 receptors activity |
| 02/15/2006 | CN1735407A Methods of using and compositions comprising dopamine reuptake inhibitors |
| 02/15/2006 | CN1733877A Conjugated linolic acid containing high content t10 and c12 |
| 02/15/2006 | CN1733801A Extraction method and uses of traditional Chinese medicine cassia seed protein |
| 02/15/2006 | CN1733773A Double(2-ethyl -3-hydroxyl-4-pyranone)copper(óÄ)complex and its uses in treating diabetes |
| 02/15/2006 | CN1733723A Indole and dihydroindole derivatives |
| 02/15/2006 | CN1733307A Antihypertensive combination of valsartan and calcium channel blocker |
| 02/15/2006 | CN1733297A Joint nutrient tablet |
| 02/15/2006 | CN1733251A Sugar reducing preparation for curing diabetes and its complication comprising astragalus root and leech and process for preparing the same |
| 02/15/2006 | CN1733245A Oral liquid for reducing sugar and process for preparing the same |
| 02/15/2006 | CN1733209A Injection for restoring pulse beat and process for preparing the same |
| 02/15/2006 | CN1733154A Capsule comprising oriental cattail pollen and red sange root and technique for preparing the same |
| 02/15/2006 | CN1733151A Health caring medical liquor containing wine processed grape |
| 02/15/2006 | CN1733143A Aimal liver concentration tablet and technique for preparing the same |
| 02/15/2006 | CN1733100A Chinese medicinal preparation for strengthening bone and generating blood and process for preparing the same |
| 02/15/2006 | CN1733089A Medicine for treating diabetes and its complications and process for preparing the same |
| 02/15/2006 | CN1733085A Application of epimeddium and other Chinese medicine in weight-reducing healthy product and medicinal preparation |
| 02/15/2006 | CN1733076A Weight reducing Chinese medicine and disposable weight-reducing dedicated catgut embedding device |
| 02/15/2006 | CN1733055A Fenugreek seed extract and its preparing process and application |
| 02/15/2006 | CN1733054A Dogwood fruit extract and its preparation process |
| 02/15/2006 | CN1733023A Red rice and gingko leaf composition for preventing and treating cardiovascular and cerebrovascular disease and its application |
| 02/15/2006 | CN1732984A Concentrated tablet of animal kidney and technique for preparing the same |
| 02/15/2006 | CN1732980A Freeze dry formulation of microelement and method for preparing the same |
| 02/15/2006 | CN1732975A Prescription of compound electrolyte drug for injection and method for preparing the same |
| 02/15/2006 | CN1732974A Medicinal composition of fructose diphosphate sodium and magnesium salt |
| 02/15/2006 | CN1732970A Breviscapine injection liquid and its preparing process |
| 02/15/2006 | CN1732958A Spray containing Vitamin D analog |
| 02/15/2006 | CN1732927A Orally administered formulation of mitiglinide calaium hydrate |
| 02/15/2006 | CN1732925A Sustained release minipills of lovastatin and its preparation process |
| 02/15/2006 | CN1732922A Soft capsule of cis form ligustilide |
| 02/15/2006 | CN1732911A Sustained releasing preparation of ferrosi succinas and its preparation method |
| 02/15/2006 | CN1732905A Directly tabletting xylitol powder and its production method |
| 02/15/2006 | CN1732902A Vitamin contained spray |
| 02/15/2006 | CN1241942C Methods for treatment of diabetes using peptide analogues of insulin |
| 02/15/2006 | CN1241929C Aminoglucose diphosphate and its synthesis method and preparation of medicine for treating stomash disease using said salt |
| 02/15/2006 | CN1241921C Fluoro isoflavone containing derivative, monufacturing method and its use |
| 02/15/2006 | CN1241912C Disulfide derivatives useful for treating allergic diseases |
| 02/15/2006 | CN1241634C Medicine for treating diabetes and its preparation process |
| 02/15/2006 | CN1241623C Capsule 'Yibao Yishou' for elongating life |
| 02/15/2006 | CN1241616C Aloe and ant capsule |
| 02/15/2006 | CN1241602C Oral administered medicated wine for treating cardiovascular and cerebrovascular diseases |
| 02/15/2006 | CN1241577C Medicine use of cyclodextrin derivatives and medicine composition thereof |
| 02/15/2006 | CN1241562C Application of forsythin in the process for preparing adiposis treating oral medicine and healthy food |
| 02/15/2006 | CN1241559C Chinese traditional medicine hypoglycemic agent and preparing process thereof |
| 02/15/2006 | CN1241545C Pharmaceutical composition |
| 02/15/2006 | CN1241499C Alfalfa plant concentrated extract preparing process |
| 02/14/2006 | US6998503 crystallized as an anhydrous, stoichiometric 1.5 HCl salt; inhibiting or modulating nitric oxide synthesis |
| 02/14/2006 | US6998422 Using pravastatin mixture with taurine, panthethine and inosiutol and hexanicotinate; anticholesterol agent, cardiovascular disorders |
| 02/14/2006 | US6998416 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/14/2006 | US6998412 Heterocyclic compounds |
| 02/14/2006 | US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic |
| 02/14/2006 | US6998407 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
| 02/14/2006 | US6998395 Controlled release formulation for preventing or treating risk factors for cardiovascular disease |
| 02/14/2006 | US6998392 Formulation to treat or prevent parasitic infection |
| 02/14/2006 | US6998263 Methods of preparing and using a viral vector library |
| 02/14/2006 | US6997863 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 02/14/2006 | CA2450740C Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/14/2006 | CA2394900C Diabetes management system |
| 02/14/2006 | CA2374643C 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists |
| 02/14/2006 | CA2363145C Oxamic acids and derivatives as thyroid receptor ligands |
| 02/14/2006 | CA2324493C Controlled release oral tablet having a unitary core |
| 02/14/2006 | CA2292586C Solid pharmaceutical dosage forms in form of a particulate dispersion |
| 02/14/2006 | CA2209825C Heterocyclic-fused pyridines |
| 02/09/2006 | WO2006014865A2 Compositions containing policosanol and chromium and/or chromium salts and their pharmaceutical uses |
| 02/09/2006 | WO2006014790A2 Compositions containing policosanol and omega-3 fatty acids and their pharmaceutical uses |
| 02/09/2006 | WO2006014787A2 Compositions containing policosanol and b vitamins and their pharmaceutical uses |
| 02/09/2006 | WO2006013954A1 Composition containing swelling agent comprising swellable water-soluble polysaccharide and food, obesity preventive, and constipation alleviator each containing the composition |
| 02/09/2006 | WO2006013929A1 Composition for accelerating calcium absorption |
| 02/09/2006 | WO2006013904A1 Medicinal composition containing meltrin antagonist |
| 02/09/2006 | WO2006013444A1 Preparations of stable pharmaceutical compositions of nateglinide and processes for their preparation |
| 02/09/2006 | WO2006013048A1 Indole, indazole or indoline derivatives |
| 02/09/2006 | WO2005118511A3 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | US20060031956 Nucleotide sequences for gene regulation and methods of use thereof |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030607 Compounds for the reduction of excessive food intake |
| 02/09/2006 | US20060030604 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 02/09/2006 | US20060030580 Contacting phenolic piperidines with opioid receptors; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction |